Drug Profile


Latest Information Update: 25 Jun 2001

Price : $50

At a glance

  • Originator Selectus Pharmaceuticals [CEASED]
  • Class Antiarrhythmics; Propanolamines; Small molecules
  • Mechanism of Action Beta-adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Angina pectoris; Anxiety disorders; Migraine

Most Recent Events

  • 25 Jun 2001 Discontinued-II for Migraine in USA (Sublingual)
  • 25 Jun 2001 Discontinued-II for Anxiety disorders in USA (Sublingual)
  • 25 Jun 2001 Discontinued-II for Angina pectoris in USA (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top